Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Cancer Radiother ; 21(1): 16-20, 2017 Feb.
Article in English | MEDLINE | ID: mdl-28041814

ABSTRACT

PURPOSE: Spermatic cord sarcoma is a rare disease, which management remains controversial due to the lack of guidelines. The standard therapeutic approach is surgical: wide soft-tissue resection with radical inguinal orchidectomy, The diagnosis is made during the analysis of the specimen. The high rate of local recurrence indicates adjuvant radiotherapy of the tumor bed. The aim of this series is to determine the efficacy and safety of postoperative intensity-modulated radiotherapy for spermatic cord sarcomas. PATIENTS AND METHODS: Our series included five consecutive cases of spermatic cord sarcoma treated between 2011 and 2014. The indications for radiotherapy were: R1 status after initial surgery, R1 status after wide en bloc resection and orchiectomy, high French federation of cancer centers (FNCLCC) grade, tumor size over 5cm, tumor resection during surgery. RESULTS: Median age at diagnosis was 66years (range 46-84years). Median follow-up was 18months (range 6-28months). Four patients had repeat surgery after incomplete removal. All surgeries were orchidectomy with primary ligation of testicular vessels. One patient did not have an in sano margin after the second surgical procedure. The median tumor size was 60mm (range 30-150mm). No recurrence was observed during the follow-up. CONCLUSION: No grade 4 toxicities were reported and the most frequent acute toxicity was dermatitis. No recurrence was reported after adjuvant intensity-modulated radiotherapy. The treatment is feasible and well tolerated and seems to provide encouraging results regarding locoregional control of the disease. Dynamic or rotational intensity-modulated radiotherapy is now recommended to decrease acute toxicities while improving the efficacy of this approach.


Subject(s)
Genital Neoplasms, Male/radiotherapy , Liposarcoma/radiotherapy , Radiotherapy, Intensity-Modulated , Spermatic Cord , Aged , Aged, 80 and over , Follow-Up Studies , Genital Neoplasms, Male/surgery , Humans , Leiomyosarcoma/radiotherapy , Leiomyosarcoma/surgery , Liposarcoma/surgery , Male , Middle Aged , Neoplasm Recurrence, Local , Orchiectomy , Organs at Risk , Radiodermatitis/epidemiology , Radiodermatitis/etiology , Radiotherapy Dosage , Radiotherapy, Intensity-Modulated/adverse effects , Radiotherapy, Intensity-Modulated/methods , Reoperation , Retrospective Studies , Treatment Outcome
2.
Int. j. med. surg. sci. (Print) ; 3(1): 735-740, 2016. ilus
Article in Spanish | LILACS | ID: lil-790599

ABSTRACT

El tumor óseo de células gigantes (TOCG) es un tumor óseo primario que se presenta con más frecuencia en la tercera edad de la vida, ubicándose principalmente a nivel del fémur distal. El desarrollo de una biopsia para su establecer su diagnóstico y poder comenzar con rapidez el tratamiento adecuado, constituye un procedimiento fundamental para poder establecer la resección quirúrgica lo más temprano posible. En este artículo se presenta un caso de TOCG en una paciente de 30 años. Se discute su etiopatogenia, signos y síntomas, diagnóstico, como así también los procedimientos diagnóstico y terapeútico adecuados para lograr una resolución positiva de esta patología.


The giant cell tumor of bone (OCD) is a primary bone tumor that occurs most frequently in the third age of life, being located mainly at the distal femur. The development of a biopsy to establish the diagnosis and to begin appropriate treatment quickly is a fundamental to establish as early as possible surgical resection procedure. In this article a case of TOCG is presented in a patient of 30 years. Its etiology, signs and symptoms, diagnosis, as well as an adequate diagnostic and therapeutic procedures to achieve a positive resolution of this pathology is discussed.


Subject(s)
Humans , Female , Adult , Bone Neoplasms/surgery , Bone Neoplasms/pathology , Knee , Giant Cell Tumor of Bone/surgery , Giant Cell Tumor of Bone/pathology , Biopsy
3.
Cancer Radiother ; 19(2): 98-105, 2015 Apr.
Article in French | MEDLINE | ID: mdl-25769650

ABSTRACT

PURPOSE: In recent decades, the management of rectal cancer has been significantly improved by optimizing the surgical treatment with the total mesorectal excision and the development of neoadjuvant radiotherapy with or without chemotherapy. In this study, we investigated the impact of changes in practice over a period of 15 years in an expert centre. PATIENTS AND METHODS: A monocentric study was conducted retrospectively on cT3-resectable T4 patients who received chemoradiotherapy for a locally advanced rectal adenocarcinoma between 1993 and 2008. We studied sphincter preservation, pathological complete response (ypT0), survival, and toxicities by different concomitant chemotherapy and treatment period. RESULTS: Among the 179 patients who had a chemoradiotherapy, 56.4% were received concomitant 5-fluoro-uracil-leucovorin, 28.5% with concomitant capecitabine, and 15.1% with concomitant oxaliplatin and capecitabine. The average dose of radiotherapy was 45 Gy (25×1.8 Gy). Five-year disease-free survival was 74.3% and overall survival 68.8%. The rate of local recurrence and distant metastases were 6.1 and 23.6%. In multivariate analysis, concomitant chemotherapy oxaliplatin and capecitabine improved the pathological complete response rate (ypT0; capecitabine: 6%, 5-fluoro-uracil-leucovorin: 10.3%, capecitabine-oxaliplatin: 22.2%), but not significantly (P=0.12) and with more toxicities, and treatment interruptions. Sphincter preservation rate was not improved significantly during the study period (1993-2004 vs. 2005-2008), but disease-free survival improved from 72.2% up to 87.5% (P=0.03). CONCLUSION: Our results are consistent with those published in the literature. Concomitant chemotherapy with 5-fluoro-uracil or capecitabine remains the standard scheme. Upfront chemotherapy, before chemoradiotherapy, should be investigated with regard to the predominance of metastasis.


Subject(s)
Adenocarcinoma/therapy , Chemoradiotherapy, Adjuvant , Neoadjuvant Therapy , Rectal Neoplasms/therapy , Adenocarcinoma/secondary , Adenocarcinoma/surgery , Adult , Aged , Aged, 80 and over , Anal Canal/injuries , Anal Canal/physiopathology , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Capecitabine , Chemoradiotherapy, Adjuvant/adverse effects , Deoxycytidine/administration & dosage , Deoxycytidine/adverse effects , Deoxycytidine/analogs & derivatives , Disease-Free Survival , Female , Fluorouracil/administration & dosage , Fluorouracil/adverse effects , Fluorouracil/analogs & derivatives , Follow-Up Studies , Humans , Kaplan-Meier Estimate , Leucovorin/administration & dosage , Leucovorin/adverse effects , Liver Neoplasms/secondary , Lung Neoplasms/secondary , Lymphatic Metastasis , Male , Middle Aged , Neoadjuvant Therapy/adverse effects , Neoplasms, Second Primary/mortality , Organoplatinum Compounds/administration & dosage , Organoplatinum Compounds/adverse effects , Oxaliplatin , Rectal Neoplasms/surgery , Retrospective Studies , Treatment Outcome
4.
Cancer Radiother ; 18(1): 59-63, 2014 Jan.
Article in French | MEDLINE | ID: mdl-24373643

ABSTRACT

Follicular dendritic cell sarcomas are a recently described entity, with biphenotypic characteristics of lymphomas and sarcomas. The treatment is hardly consensual in the literature. We report two head and neck cases, of favorable outcome after surgery and radiotherapy. Histopathology and differential diagnoses are discussed as well as the therapeutic strategies used.


Subject(s)
Dendritic Cell Sarcoma, Follicular/radiotherapy , Head and Neck Neoplasms/radiotherapy , Parotid Neoplasms/radiotherapy , Radiotherapy, Conformal , Aged, 80 and over , Castleman Disease/complications , Combined Modality Therapy , Dendritic Cell Sarcoma, Follicular/pathology , Dendritic Cell Sarcoma, Follicular/surgery , Dose Fractionation, Radiation , Female , Head and Neck Neoplasms/pathology , Head and Neck Neoplasms/surgery , Humans , Middle Aged , Neoplasms, Second Primary/radiotherapy , Neoplasms, Second Primary/surgery , Parotid Neoplasms/pathology , Parotid Neoplasms/surgery
5.
Enferm Infecc Microbiol Clin ; 17(6): 292-9, 1999.
Article in Spanish | MEDLINE | ID: mdl-10439540

ABSTRACT

OBJECTIVE: Infectious pharyngotonsillitis is usually managed with antibiotics by general practitioners and pediatricians both in primary care and the emergency services. In the present work we try to assess the antibiotic variability and appropriateness in the management of acute pharyngotonsillitis among several emergency services in our country related to scientific evidence based in an expert panel criteria. METHOD: A transversal trial was carried on in ten emergency services of our country. We included patients older than fourteen years an analyzed the following variables: type of respiratory infection, antibiotic prescription, comorbidity, physician's status and hospital admission. The antibiotics were classified in three levels according to the expert panel criteria: first election, alternative use and inappropriate use. We compared the antibiotic treatments to these three levels. RESULTS: 2,869 patients were diagnosed of acute respiratory infection, 356 (12.4%) with pharyngotonsillitis. Commonly the patients were prescribed antibiotics (315; 81%) and the most used were amoxicillin-clavulanate (33%), amoxicillin (16%), penicillin (7%), cefuroxime (6%), erythromicin (4%) and cefixime (3%). Among the 315 prescriptions, 98 (32%) were first election, 147 (50%) alternative use and 50 (17%) inappropriate use. CONCLUSIONS: Most of the patients suffering of pharyngotonsillitis were empirically prescribed antibiotics probably many of these cases were non-bacterial pharyngotonsillitis. Alternative and inappropriate use of antibiotics was high.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Pharyngitis/drug therapy , Tonsillitis/drug therapy , Acute Disease , Adolescent , Adult , Aged , Drug Utilization , Emergency Service, Hospital , Female , Humans , Male , Middle Aged , Practice Patterns, Physicians' , Spain
6.
Rev Esp Quimioter ; 12(4): 352-8, 1999 Dec.
Article in Spanish | MEDLINE | ID: mdl-10855015

ABSTRACT

We performed a study to evaluate the variability and adequacy of prescribing antibiotics in community-acquired pneumonia (CAP) in 10 Spanish hospitals. We studied 452 patients with CAP. Initial empirical administration of antibiotics was prescribed in 90.7% of the cases, 82.5% as monotherapy. Macrolides and third and second generation cephalosporins were the most widely used groups of antibiotics. Penicillin and amoxicillin were only prescribed in 1. 7% of the patients. A significant variability between hospitals was observed. Reference patterns for the use of antibiotics in CAP were devised by a panel of experts. According to the recommendations of this panel, 29% of the total prescriptions were not adequate, with this percentage reaching 65% in outpatients older than 65 years or with comorbidity. This was mainly due to the fact that monotherapy with erythromycin, which was considered inadequate, was the most widely prescribed treatment.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Pneumonia, Bacterial/drug therapy , Adult , Aged , Community-Acquired Infections/drug therapy , Cross-Sectional Studies , Drug Prescriptions/standards , Female , Humans , Male , Middle Aged
7.
Rev Esp Quimioter ; 12(4): 352-358, 1999.
Article in Spanish | MEDLINE | ID: mdl-10878528

ABSTRACT

We performed a study to evaluate the variability and adequacy of prescribing antibiotics in community-acquired pneumonia (CAP) in 10 Spanish hospitals. We studied 452 patients with CAP. Initial empirical administration of antibiotics was prescribed in 90.7% of the cases, 82.5% as monotherapy. Macrolides and third and second generation cephalosporins were the most widely used groups of antibiotics. Penicillin and amoxicillin were only prescribed in 1.7% of the patients. A significant variability between hospitals was observed. Reference patterns for the use of antibiotics in CAP were devised by a panel of experts. According to the recommendations of this panel, 29% of the total prescriptions were not adequate, with this percentage reaching 65% in outpatients older than 65 years or with comorbidity. This was mainly due to the fact that monotherapy with erythromycin, which was considered inadequate, was the most widely prescribed treatment.

8.
Arch Bronconeumol ; 34(8): 384-7, 1998 Sep.
Article in Spanish | MEDLINE | ID: mdl-9803275

ABSTRACT

OBJECTIVE: To examine the role of naive and memory T cells (as determined by CD45 isoforms) in recent tuberculosis infection and in pulmonary and pleural forms to the disease. To relate such subpopulations to serum levels of soluble IL-2 receptor (sIL-2R) and interleukin-6 (IL-6). METHODS: T cell subpopulations (CD3, CD4, CD8), naive (CD45RA), memory (CD45RO) and activated CD24+ T cells (IL-2 receptor) were measured in the peripheral blood and pleura of patients with recent tuberculosis infection (n = 7), pulmonary tuberculosis (n = 22) and tuberculosis pleurisy (n = 12). Serum levels of sIL-2 and IL-6 were determined in 13 patients with pleural or pulmonary tuberculosis and their relation to CD45RA and CD45RO subsets was analyzed. RESULTS: T lymphocytosis involving all the subpopulations studied, including naive and memory T cells, was detected, although the RA:RO ratio did not change in relation to control levels. Marked increases in memory T cells and CD24+ T cells were found for patients with tuberculous pleurisy. sIL-2 and IL-6 levels were unrelated to naive and memory T cell subpopulations. CONCLUSIONS: T lymphocytosis involving all T cell subsets can be observed in recent tuberculosis infection; both naive and memory T cells are implicated, although neither one predominates over the other. In tuberculous pleurisy there is compartmentalization of memory and activated T cells, which presumably play important roles in the local immune response to Mycobacterium tuberculosis.


Subject(s)
Pleural Effusion/immunology , T-Lymphocyte Subsets/immunology , Tuberculosis, Pleural/immunology , Tuberculosis, Pulmonary/immunology , Adolescent , Adult , Aged , Humans , Immunologic Memory , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...